Prosecutors allege his licenses across all 48 contiguous states supplied the professional reach needed to connect mobile cardiovascular testing at college campuses with insurance claims submitted nationwide
WASHINGTON, DC — Federal prosecutors allege that cardiologist Jason Finkelstein’s licenses across every contiguous state supplied a critical expansion mechanism for a cardiovascular screening operation that reached student athletes at colleges and universities throughout the country.
The federal indictment published by the Justice Department states that Finkelstein’s multistate licensing enabled him and his alleged co-conspirators to submit claims involving students from schools nationwide through two Texas professional associations that he owned.
Prosecutors characterize those licenses as infrastructure supporting an alleged scheme involving medically unnecessary testing, false diagnoses, disputed service locations, inadequately credentialed sonographers, cursory electronic approvals, insurer appeals, and payments flowing among several related businesses.
Finkelstein has pleaded not guilty and remains presumed innocent, meaning the government must prove knowing criminal participation through admissible evidence rather than inviting jurors to treat widespread licensing, remote medicine, business growth, or national reach as inherently suspicious.
Forty-Eight Licenses Allegedly Created a National Billing Bridge
Medical practice remains principally licensed at the state level, so a physician seeking to order, supervise, interpret, or bill services involving patients across numerous jurisdictions commonly needs authority that matches the locations and activities covered by each applicable rule.
According to prosecutors, Finkelstein’s unusually broad licensing footprint removed a geographic limitation that otherwise could have restricted the operation’s ability to associate one physician with cardiovascular testing at distant schools and bill multiple benefit programs.
The indictment does not allege that obtaining many licenses was itself unlawful, and responsible analysis must separate the legitimacy of each professional authorization from the government’s claim that those authorizations were later used to facilitate materially false submissions.
That distinction will matter at trial because a valid license can establish permission to practice within a jurisdiction, but it does not automatically prove medical necessity, accurate coding, adequate examination, meaningful image review, proper staffing, or truthful billing.
A Florida Operation and Texas Billing Entities Shared Distinct Roles
The charging document describes an unnamed cardiovascular company based in Boca Raton, Florida, where Finkelstein allegedly served as medical director while two unnamed co-conspirators operated the business and directed its day-to-day activities throughout the alleged period.
That Florida company allegedly marketed testing to schools, employed traveling sonographers, gathered student information, and conducted campus events, while Cardiovascular Testing Services PA and Cardiovascular Healthcare Associates PA allegedly submitted related claims from Texas.
Prosecutors say Finkelstein owned both Texas professional associations, creating a structure in which Florida-based recruitment and mobile testing could connect with a physician whose licenses supported claims tied to patients across the contiguous United States.
The corporate separation also creates important attribution questions, because jurors must determine who controlled school outreach, technician hiring, credential verification, medical questionnaires, diagnosis selection, electronic review, claim transmission, appeals, banking, and distribution of resulting payments.
Campus Access Supplied the Alleged Patient Pipeline
Prosecutors allege that company personnel contacted athletic trainers at colleges and universities with offers of cardiovascular testing promoted as protection against life-threatening abnormalities and sudden cardiac arrest among otherwise active student athletes seeking dependable protection.
The indictment says some athletic trainers received or were offered checks, wire transfers, gift cards, or other inducements for student referrals, while participants at certain schools were allegedly told that testing was mandatory for team eligibility.
Once they secured access, traveling sonographers allegedly administered nearly the same six-test panel to nearly every athlete, including electrocardiograms, echocardiograms, and several vascular ultrasound studies conducted during organized campus visits across the country.
The nationwide license portfolio allegedly gave the operation a physician identity that could appear across this expanding map of encounters, but prosecutors still must connect each relevant school event to specific records, personnel, representations, and claims.
Licensing Breadth Did Not Establish Medical Necessity
The government’s theory depends upon a difference between professional authority and reimbursement eligibility, because holding a medical license in a student’s state does not independently establish that a diagnostic cardiovascular test was clinically indicated or covered.
According to the indictment, commercial insurers, the Federal Employees Health Benefits Program, the Veterans Health Administration, and Medicaid generally required an individualized medical-necessity determination before paying for diagnostic cardiovascular testing, subject to limited exceptions.
Prosecutors allege that Finkelstein did not examine the athletes beforehand, although claims purportedly identified him as the ordering or referring provider for services supposedly justified by symptoms, diagnoses, or clinical circumstances recorded in supporting documentation.
The defense may challenge that account by identifying medical histories, questionnaire responses, standing protocols, delegated assessments, payer-specific rules, or other evidence suggesting that particular tests carried legitimate diagnostic value despite the government’s broader characterization.
False Diagnoses Allegedly Converted Screening into Covered Testing
The indictment alleges that false diagnosis codes, including hypertension and elevated blood pressure, were assigned to student questionnaires so insurers would view broadly offered screening panels as medically necessary diagnostic services eligible for reimbursement.
This allegation makes state licensure only one component within a larger claimed conversion process, because geographic authority allegedly allowed nationwide ordering while diagnosis entries purportedly supplied the clinical justification needed for payment under applicable coverage rules.
At trial, prosecutors may compare questionnaires, vital signs, athlete histories, diagnosis records, coding instructions, claim files, employee communications, and payer guidelines to argue that conditions were deliberately created rather than reasonably inferred from available information.
Defense attorneys can examine whether administrative personnel selected codes independently, software carried information forward automatically, ambiguous answers supported genuine concern, or inaccurate entries reflected negligence and workflow mistakes rather than Finkelstein’s knowing direction.
Place-of-Service Codes Could Reveal the Geographic Mismatch
Prosecutors allege that claims falsely indicated testing occurred at Finkelstein’s office in Tarrant County, Texas, although sonographers actually acquired images during mobile events held on school campuses elsewhere across the United States during the charged period.
Place-of-service information can affect network status, reimbursement methodology, supervision rules, credentialing requirements, payer review, and state jurisdiction, making geographic accuracy potentially material rather than merely descriptive within a complex multistate billing system for claims seeking reimbursement.
The government may use campus schedules, travel records, equipment logs, image metadata, claim fields, platform exports, and school contracts to map where services occurred against the locations represented to each insurer during every disputed campus event.
The defense may argue that billing conventions distinguished technical acquisition from professional interpretation, that software populated office information automatically, or that any inaccurate location field was immaterial, unintentional, and attributable to someone else.
A Physician License Could Not Substitute for Sonographer Credentials
The indictment separately alleges that the Florida company employed sonographers lacking requisite credentials to travel to campuses and perform cardiovascular testing, although it does not identify the workers, missing qualifications, affected states, or controlling requirements.
Finkelstein’s physician licenses would not necessarily cure a technician’s deficiency if a state, insurer, school contract, accreditation framework, or employer policy required the person acquiring images to hold a particular certification, registration, or documented competency.
Conversely, the phrase describing allegedly missing credentials cannot responsibly be translated into a claim that every sonographer was untrained, legally prohibited, or clinically incompetent, because the public filing leaves the governing qualification standards unresolved.
Prosecutors will need evidence linking identifiable technicians with specific campus assignments and applicable rules, while the defense can present certifications, training files, supervision records, exemptions, contractual language, and reasonable-reliance evidence for those encounters.
Electronic Systems Allegedly Turned Reach into Volume
Multistate licenses can expand professional availability, but a national operation also requires technology that can move questionnaires, images, reports, signatures, claims, and payments between campuses, administrators, physicians, billing platforms, and insurers across state boundaries at scale.
Prosecutors allege that Finkelstein used an electronic records platform to approve cardiovascular results within only seconds, even when image collections supposedly required careful review before a cardiologist could issue a reliable interpretation under the circumstances described.
Those timestamps may support the government’s argument that one widely licensed physician supplied scalable electronic approvals for a high-volume enterprise, although digital logs require authentication and careful explanation before jurors can infer what happened clinically.
Defense experts may examine earlier access, downloaded images, preliminary readers, shared workflows, system clocks, automated events, platform migrations, and whether the recorded signature represented substantive interpretation or final administrative confirmation after prior review.
One Athlete’s Death Gives the Allegations Human Gravity
The indictment describes an October 2024 examination containing approximately 63 images, some bearing unconfirmed references to possible right-sided heart enlargement before Finkelstein allegedly signed the complete collection as normal within roughly eleven seconds.
Prosecutors say the athlete died from sudden cardiac arrest approximately twenty-four days later, creating an emotionally powerful episode that may illuminate alleged review failures while also demanding careful separation of professional responsibility, causation, intent, and fraud.
The athlete’s death does not independently prove that the testing lacked medical necessity, that claims contained deliberate falsehoods, that a licensing decision furthered conspiracy, or that Finkelstein knowingly caused any particular billing representation.
Defense lawyers may challenge the meaning of preliminary annotations, imaging quality, platform timing, medical significance, later events, cause of death, and how duties were allocated among sonographers, physicians, schools, athletes, and other healthcare providers.
The Alleged Payer Reach Was Nearly as Broad as the Geography
The government identifies several commercial insurers alongside programs serving federal employees, veterans, and Medicaid recipients, demonstrating how a single alleged workflow could encounter different coverage rules, claim formats, enrollment requirements, and audit systems.
Prosecutors will need to show that disputed representations were material under the requirements governing each charged transaction, rather than assuming a field important to one insurer carried the same meaning for every other benefit program.
Multistate practice can magnify these differences because state regulations, managed-care contracts, professional enrollment rules, network arrangements, and supervision standards may change whenever the operation crosses another jurisdictional or payer boundary during nationwide expansion.
The defense may use those variations to challenge aggregate conclusions, while prosecutors can argue that repeated diagnoses, uniform test panels, office-location codes, rapid approvals, and coordinated appeals reveal a consistent deceptive design despite administrative differences.
Financial Scale Followed the Alleged Geographic Expansion
The indictment alleges that the participants submitted more than $89 million in false claims between approximately January 2019 and December 2025, generating more than $13.1 million in payments to accounts associated with the two Texas entities.
Prosecutors further allege that Finkelstein received approximately $1.1 million through checks and wires connected with reimbursements, while the indictment seeks a forfeiture money judgment of approximately $13.15 million following qualifying convictions.
Those figures represent different concepts, because billed charges, allowed reimbursements, personal compensation, legitimate service value, actual loss, intended loss, restitution, forfeiture, and traceable proceeds require separate evidence and potentially different legal calculations under federal law.
A large license portfolio may help explain how the alleged operation reached sufficient volume to produce those totals, but scale alone cannot establish that every service was unnecessary, every claim false, or every payment criminally derived.
Four Counts Will Require Transaction-Specific Proof
Finkelstein faces one count alleging conspiracy to commit healthcare fraud and wire fraud, followed by three substantive healthcare-fraud counts associated with two abdominal aorta ultrasound claims and one larger cardiovascular testing panel identified in the indictment.
The government must prove the required agreement, knowledge, intent, material deception, and specific executions beyond a reasonable doubt, even if evidence concerning nationwide licensing helps jurors understand how prosecutors say the broader enterprise functioned.
For each substantive count, jurors may examine where the athlete attended school, who arranged testing, which technician acquired images, what diagnosis appeared, how Finkelstein became associated with the encounter, and what information reached the insurer.
The defense can insist that generalized evidence about national reach cannot replace proof concerning the selected transactions, while prosecutors may use repeated procedures and shared corporate infrastructure to explain why those claims were not isolated mistakes.
Licensing Records May Become an Evidentiary Road Map
State licensing files can establish application dates, active periods, practice addresses, disciplinary disclosures, renewal histories, attestations, and professional authority, helping lawyers reconstruct when the alleged operation possessed geographic capacity to enter particular markets.
However, a license roster does not reveal automatically whether Finkelstein examined an athlete, reviewed an image, ordered a test, selected a code, approved a claim, knew a technician’s qualifications, or understood a payer’s requirements.
Prosecutors may therefore combine licensing records with emails, contracts, school calendars, platform logs, claims, bank transfers, staffing assignments, malpractice communications, and testimony demonstrating how professional authorization allegedly supported operational expansion during the charged period.
Defense lawyers can seek evidence that licensing was obtained for legitimate cardiology, telemedicine, consultation, or future business purposes unrelated to the school program, challenging any suggestion that the portfolio existed principally to facilitate the charged conduct.
Knowledge Will Separate Infrastructure from Criminal Participation
The prosecution cannot establish conspiracy merely by showing that Finkelstein held useful licenses or owned billing entities, because federal fraud charges require evidence that he knowingly and willfully participated in the charged unlawful agreement and its execution.
Prosecutors may rely on ownership, medical-director responsibilities, repeated electronic approvals, compensation, payer appeals, internal communications, national licensing, disputed location fields, and continued conduct after warnings to infer knowing participation in the alleged scheme.
The defense can divide operational responsibilities among executives, billers, coders, technicians, software vendors, credentialing personnel, and school representatives, arguing that Finkelstein reasonably relied upon others for administrative facts outside his direct clinical role.
Jurors must distinguish deliberate avoidance from ordinary delegation, because large healthcare organizations depend upon specialized employees, yet professional complexity cannot shield a participant who consciously ignores clear evidence that material representations are false.
An August 2022 Exchange May Test the Limits of Delegation
The indictment describes a text exchange concerning abdominal aorta ultrasounds in which Finkelstein allegedly indicated that he did not read those studies, although claims connected with that service purportedly continued until approximately January 2024.
Prosecutors may present the exchange as notice that billed services and actual review practices diverged, especially when combined with nationwide claims submitted to multiple insurers that identify Finkelstein as an ordering, servicing, rendering, or reviewing physician.
Defense attorneys can demand the complete conversation, workflow assignments, terminology, surrounding records, and witness explanation, contending that brief messages can be misunderstood when separated from the operational context governing professional and technical components.
The exchange will carry persuasive force only if authenticated evidence connects its meaning with charged transactions and required intent, rather than inviting jurors to treat an isolated fragment as a complete explanation of years of practice.
Multistate Practice Is Common and Often Beneficial
Telemedicine, specialist consultations, remote imaging, locum coverage, mobile diagnostics, and national clinical networks can improve access when they operate through appropriate licenses, accurate patient-location procedures, qualified personnel, meaningful review, and truthful reimbursement practices.
The Finkelstein allegations should therefore prompt stronger controls without stigmatizing physicians who lawfully maintain numerous licenses or organizations that coordinate legitimate services across state boundaries for underserved patients and institutions throughout the United States.
The central compliance lesson is aligning geographic authority with actual conduct, because every service should accurately connect the patient’s location, clinician’s authorization, technician’s qualifications, ordering rationale, interpretation record, and claim representation.
When those elements become fragmented across multiple businesses and software systems, a national license portfolio can accelerate legitimate access or magnify hidden errors, depending on whether governance expands as carefully as commercial reach.
Healthcare Groups Need a State-by-State Control Matrix
Organizations operating nationwide should maintain a current matrix identifying physician licenses, renewal deadlines, practice restrictions, patient-location rules, technician requirements, supervision standards, corporate-practice limitations, telemedicine conditions, prescribing rules, and payer-enrollment obligations across every jurisdiction served.
That matrix should connect directly with scheduling and billing systems, preventing an encounter from proceeding when the assigned professional lacks authority, a credential has expired, a required supervisor is unavailable, or enrollment information conflicts with claim data.
Compliance teams should also verify whether a campus event constitutes screening, diagnosis, mobile imaging, telemedicine, or another regulated activity, because marketing labels may not determine the legal or reimbursement classification.
Regular testing should compare service locations, patient addresses, ordering providers, rendering professionals, technician identities, image timestamps, diagnostic codes, and payer submissions, so discrepancies surface before national volume turns isolated weaknesses into systemic exposure.
Schools Cannot Outsource Every Responsibility to Vendors
Colleges considering outside cardiovascular programs should verify corporate identities, physician licenses, technician credentials, referral compensation, insurance arrangements, clinical protocols, data safeguards, result-review procedures, and emergency escalation responsibilities before granting student athletes campus access.
Written agreements should identify who orders each test, who determines medical necessity, where technical and professional services occur, which entity bills insurers, how students provide informed consent, and whether participation affects athletic eligibility.
Athletic departments should preserve vendor proposals, credential packets, event rosters, communications, consent forms, equipment records, incident reports, claims disclosures, and abnormal-result notices, ensuring later questions can be answered through evidence rather than memory.
National branding and an extensive physician license portfolio can appear reassuring, but those features do not replace school-level verification that every person performing or interpreting services is qualified and accountable for the work promised.
Athletes Deserve Transparent Information Before Participation
Student athletes should receive understandable notice explaining whether testing is optional, why each procedure is recommended, who will acquire and interpret images, what qualifications those professionals possess, and which insurer may receive a claim.
They should also know which diagnoses could enter their medical records, how to obtain complete results, who will communicate urgent findings, whether independent follow-up is available, and how to correct disputed billing information.
A representation that campus testing carries no direct student cost does not answer whether the service is necessary, accurately documented, competently performed, properly billed, or supported by a reliable process for responding to dangerous abnormalities.
Clear disclosure protects informed choice while helping schools and insurers spot when a program’s stated preventive purpose conflicts with claim descriptions that present the same encounters as individualized diagnostic care before any testing begins.
Insurers Can Detect Geographic Inconsistencies Earlier
Health plans can compare physician license data with campus calendars, patient locations, technician rosters, identical test bundles, diagnosis patterns, place-of-service codes, review intervals, corporate addresses, appeals, and bank relationships across submitted claims over time.
Unusual patterns should trigger proportionate review rather than automatic accusations, because legitimate mobile services, remote interpretation, software defaults, delegated workflows, and multisite corporate structures can create anomalies without establishing intentional healthcare fraud in any transaction.
Payers should publish clear requirements for mobile testing, professional and technical components, remote review, credential documentation, ordering-provider relationships, and service locations on every claim, reducing ambiguity before money changes hands and enforcement disputes begin.
Earlier coordination among credentialing, special investigations, clinical review, and claims teams can reveal when one physician’s national footprint supports volumes or geographic combinations that warrant verification through complete underlying records and direct provider inquiries when necessary.
Reputable Reporting Has Focused on the Scaling Allegation
Associated Press reporting described prosecutors’ claim that Finkelstein’s licenses across the contiguous states enabled nationwide billing, while placing that allegation within a broader federal healthcare-fraud crackdown and reporting his not-guilty plea during court proceedings.
The coverage also highlighted allegations concerning unneeded tests, false diagnoses, traveling sonographers, rapid approvals, and the death of a student athlete, demonstrating why the case reaches beyond technical licensing administration into patient safety and public trust.
Responsible reporting must nevertheless attribute every contested accusation, distinguish claims submitted from reimbursements paid, avoid treating the indictment as evidence, and preserve Finkelstein’s presumption of innocence throughout coverage of all future court proceedings.
Public Communication Should Separate Licensure from Guilt
Healthcare organizations confronting comparable scrutiny need disciplined communication that explains verified licensing facts, preserves patient privacy, avoids influencing witnesses, corrects demonstrable inaccuracies, and never presents an accusation, internal review, or professional credential as conclusive proof.
Amicus International Consulting’s crisis public relations guidance emphasizes structured assessment and planned messaging, principles that can help organizations communicate consistently while counsel preserves evidence, evaluates multistate obligations, and manages disclosures during extended litigation.
Its approach to rebuilding a damaged public reputation similarly supports sustained, verifiable communication, although ethical reputation work cannot erase authentic licensing records, manufacture compliance, suppress legitimate journalism, or replace corrective action after proven misconduct.
Statements should identify what remains alleged, what records have been reviewed, which safeguards are operating, and how affected patients or institutions can obtain information without speculating about guilt before evidence receives adversarial testing.
The Case Is Scheduled for an April 2027 Trial
The federal case remains pending before Judge Aileen Cannon in West Palm Beach, with a September 2026 status conference, a March 2027 calendar call, and jury trial currently scheduled to begin April 5, 2027.
Those dates may change through later orders addressing discovery, expert evidence, motions, witness availability, negotiations, or other developments, while the currently published schedule remains the operative timetable unless the court directs otherwise by order.
Licensing evidence may help jurors understand the alleged scheme’s geographic architecture, but the verdict must turn upon whether prosecutors prove every charged element through reliable evidence connected with Finkelstein’s knowledge and specific conduct.
Finkelstein has no obligation to prove innocence, and any reasonable doubt concerning intent, attribution, medical necessity, credentialing, claim accuracy, location information, professional review, or participation must be resolved under the court’s final instructions.
National Reach Makes Precision More Important, Not Less
The prosecution presents Finkelstein’s 48-state licensing as the professional backbone of an alleged operation that connected campus recruitment, mobile testing, electronic review, Texas billing entities, interstate claims, and payments across a six-year period.
That theory gives jurors a coherent explanation for scale, yet it cannot substitute for evidence proving who made each representation, why it mattered, what Finkelstein knew, and how the selected transactions satisfied federal criminal statutes.
For healthcare organizations, the case demonstrates that geographic growth requires equally scalable credentialing, clinical governance, data integrity, billing controls, and accountability, especially when one professional identity supports services delivered by dispersed teams across numerous jurisdictions.
For schools and athletes, it underscores that broad licensing may establish legal reach while leaving essential questions about necessity, competence, review, consent, billing, and follow-up unanswered unless contracts and operational records supply transparent assurances.
Jason Finkelstein remains presumed innocent, and the government’s allegation that his licenses enabled nationwide fraudulent claims will remain an accusation unless prosecutors prove it beyond a reasonable doubt through evidence tested before a jury.
Audit: 3,458 prose words; 100 complete sentences; shortest sentence 33 words; exactly four hyperlinks in the required distribution